Flow Cytometry News and Research RSS Feed - Flow Cytometry News and Research

Flow cytometry is a technique for counting and examining microscopic particles suspended in a stream of fluid. It allows simultaneous multiparametric analysis of the physical and/or chemical characteristics of single cells flowing through an optical and/or electronic detection apparatus.
Adaptive Biotechnologies demonstrates use of high-throughput sequencing platform for MRD

Adaptive Biotechnologies demonstrates use of high-throughput sequencing platform for MRD

Adaptive Biotechnologies, the leader in combining next-generation sequencing (NGS) and expert bioinformatics to profile T- and B-cell receptors of the adaptive immune system, and collaborators will be presenting five studies demonstrating how Adaptive’s high-throughput sequencing platform enables diagnosis, detection and assessment of prognosis in hematological malignances and has increased sensitivity over flow cytometry. [More]
Already-approved drugs can fight apoptosis evasion in cancer

Already-approved drugs can fight apoptosis evasion in cancer

Cancer cells don't die when they're supposed to. Animal and human bodies follow an orderly process of birthing new cells and killing old ones. But cancer cells escape programmed cell death, called apoptosis, and multiply uncontrollably. [More]
Metformin along with chemotherapy/radiation improves outcomes in head and neck cancer patients

Metformin along with chemotherapy/radiation improves outcomes in head and neck cancer patients

Researchers at the University of Cincinnati College of Medicine have found that adding increasing doses of an approved Type 2 diabetes drug, metformin, to a chemotherapy and radiation treatment regimen in head and neck cancer patients is not well tolerated if escalated too quickly, but allowing slower escalation could be beneficial. [More]
Phase 2 results of AbbVie’s venetoclax in patients with R/R CLL with 17p deletion published in The Lancet Oncology

Phase 2 results of AbbVie’s venetoclax in patients with R/R CLL with 17p deletion published in The Lancet Oncology

AbbVie, a global biopharmaceutical company, today announced The Lancet Oncology published results from the Phase 2, single arm, open label trial studying venetoclax in patients with relapsed/refractory (R/R) chronic lymphocytic leukaemia (CLL) with 17p deletion. [More]
Vegetable-based polyphenol enhances wound healing

Vegetable-based polyphenol enhances wound healing

A research group led by Osaka University found a plant-based polyphenol, promotes the migration of Mesenchymal Stem Cells (MSCs) in blood circulation and accumulates them in damaged tissues to improve wound healing. It is anticipated that the results will be used for stem cell treatments for cutaneous disorders associated with various damage and lesions. [More]
Beckman Coulter Life Sciences’ Yong Chen recognized as AIMBE Fellow

Beckman Coulter Life Sciences’ Yong Chen recognized as AIMBE Fellow

One of the world’s leading organizations for medical and engineering innovation and discovery has elected Dr. Yong Chen, the Chief Technology Officer of Beckman Coulter Life Sciences, a Danaher company, to its College of Fellows. The American Institute for Medical and Biological Engineering has honored Dr. Yong Chen in recognition of his work in the field of medical and engineering innovation and discovery. [More]
Extracellular vesicle isolation and characterization: an interview with Dr Carley Ross

Extracellular vesicle isolation and characterization: an interview with Dr Carley Ross

Extracellular vesicles are membrane surrounded structures released by cells in an evolutionally conserved manner. There are three main types of EVs, Exosomes (50-100 nm), Microparticles (200 nm-1 um) and Apoptotic bodies. [More]
Wistar researchers find potential way for using STAT3 inhibitors to stop cancer progression

Wistar researchers find potential way for using STAT3 inhibitors to stop cancer progression

Imagine developing a drug designed to inhibit a protein that helps cancer cells proliferate and survive only to find that the drug does not perform very well in the clinic. This was the dilemma faced by scientists researching inhibitors of signal transducer and activator of transcription (STAT3), a protein that controls transcription by the STAT3 gene. [More]
UAB research reveals heterogonous population of leukemia stem cells

UAB research reveals heterogonous population of leukemia stem cells

University of Alabama at Birmingham researchers have found a marker on blood cells that may help the most pressing problem in chronic myelogenous leukemia, or CML, today — an inability to get patients off treatment. [More]
Immunological changes during pregnancy may influence response to influenza vaccination

Immunological changes during pregnancy may influence response to influenza vaccination

In a study to be presented on Feb. 5 in an oral concurrent session at 1:15 p.m. EST, at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting, in Atlanta, researchers will present findings from a study titled, T-follicular helper (Thf) cell expansion varies by trimester after influenza vaccination in pregnancy. [More]
Rockland announces availability of new human melanoma cell lines

Rockland announces availability of new human melanoma cell lines

Rockland Immunochemicals, Inc. announces the availability of a new collection of human melanoma cell lines that have been developed and characterized over several decades in the laboratory of Meenhard Herlyn, D.V.M., D.Sc., Caspar Wistar Professor in Melanoma Research, Director of the Melanoma Research Center, and professor in the Molecular and Cellular Oncogenesis Program at The Wistar Institute in Philadelphia. [More]
Using centrifugal elutriation and flow cytometry to answer biological questions: an interview with Peter Lopez

Using centrifugal elutriation and flow cytometry to answer biological questions: an interview with Peter Lopez

Flow Cytometry, the measurement of various cellular characteristics as they flow through a measuring apparatus, has so many applications that it's hard to know where to begin. [More]
NeoGenomics acquires Clarient and Clarient Diagnostic Services

NeoGenomics acquires Clarient and Clarient Diagnostic Services

NeoGenomics, Inc., a leading provider of cancer-focused genetic testing services, announced today that it has completed the acquisition of Clarient, Inc. and its wholly-owned subsidiary Clarient Diagnostic Services, Inc. Clarient, a provider of comprehensive cancer diagnostic testing to hospitals, physicians and the pharmaceutical industry, was a unit of GE Healthcare's Life Sciences business. [More]
Researchers identify biochemical factors that may predict Alzheimer's disease

Researchers identify biochemical factors that may predict Alzheimer's disease

Investigators have wondered why the brains of some cognitively-intact elderly individuals have abundant pathology on autopsy or significant amyloid deposition on neuroimaging that are characteristic of Alzheimer disease (AD). [More]
UCL Cancer Institute win $200,000 CytoFLEX Flow Cytometer from Beckman Coulter

UCL Cancer Institute win $200,000 CytoFLEX Flow Cytometer from Beckman Coulter

An internationally renowned gene therapy research team has won a $200,000 CytoFLEX Flow Cytometer from Beckman Coulter Life Sciences. The contest was designed to explore innovative research solutions involving flow cytometry. [More]
A glass of clean drinking water contains 10 million bacteria

A glass of clean drinking water contains 10 million bacteria

Researchers from Lund University in Sweden have discovered that our drinking water is to a large extent purified by millions of "good bacteria" found in water pipes and purification plants. So far, the knowledge about them has been practically non-existent, but this new research is about to change that. [More]
BD announces launch of BD FACSCelesta flow cytometer during ASCB annual meeting

BD announces launch of BD FACSCelesta flow cytometer during ASCB annual meeting

BD (Becton, Dickinson and Company), a leading global medical technology company, today announced the launch of the BD FACSCelesta flow cytometer during the 2015 American Society for Cell Biology annual meeting. Uniquely designed to leverage the broad BD Horizon Brilliant reagent portfolio, this new system offers simultaneous measurement of up to 14 different single cell characteristics. [More]
NeoGenomics introduces NeoLAB Solid Tumor Monitor, NeoLAB BTK Inhibitor Acquired Resistance test

NeoGenomics introduces NeoLAB Solid Tumor Monitor, NeoLAB BTK Inhibitor Acquired Resistance test

NeoGenomics, Inc., a leading provider of cancer-focused genetic testing services, announced today an expansion of its liquid biopsy testing menu to include two new tests, a NeoLAB Solid Tumor Monitor and a NeoLAB BTK Inhibitor Acquired Resistance test. [More]
Excellence in graduate student research, third annual Kaluza prizes

Excellence in graduate student research, third annual Kaluza prizes

Beckman Coulter Life Sciences has again collaborated with the American Society for Cell Biology (ASCB) to sponsor the Third Annual ASCB Kaluza Prizes for academic excellence in graduate student research. [More]
HPV research partnership signed between Beckman Coulter and IncellDx

HPV research partnership signed between Beckman Coulter and IncellDx

Beckman Coulter Life Sciences and IncellDx, Inc. announced today they have signed a distribution agreement which focuses exclusively on clinical researchers in China, Hong Kong and Taiwan working on the Human Papilloma Virus (HPV) and cancer. [More]
Advertisement
Advertisement